Covered recipient · General Payments record
YIAN J JONES
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$1,652.34
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $630.85 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $471.70 | 12 |
| ABBVIE INC. | $91.75 | 4 |
| BIOTISSUE HOLDINGS INC. | $23.87 | 1 |
| Astellas Pharma US Inc | $23.57 | 1 |
| Tarsus Pharmaceuticals, Inc. | $19.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.20 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010196 | CMS |
| ABBVIE INC. | $25.13 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010198 | CMS |
| ABBVIE INC. | $20.45 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010200 | CMS |
| ABBVIE INC. | $21.97 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010202 | CMS |
| Amgen Inc. | $18.05 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115773250 | CMS |
| Amgen Inc. | $1.03 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115773266 | CMS |
| Amgen Inc. | $0.93 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115773276 | CMS |
| Amgen Inc. | $17.07 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115773258 | CMS |
| Amgen Inc. | $15.84 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115773284 | CMS |
| Amgen Inc. | $4.13 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115773293 | CMS |
| Amgen Inc. | $19.59 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115773304 | CMS |
| Amgen Inc. | $2.13 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115773312 | CMS |
| Amgen Inc. | $196.66 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115773328 | CMS |
| Amgen Inc. | $135.67 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115773320 | CMS |
| Amgen Inc. | $30.40 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115773339 | CMS |
| Amgen Inc. | $30.20 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115773347 | CMS |
| Astellas Pharma US Inc | $23.57 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139327284 | CMS |
| BIOTISSUE HOLDINGS INC. | $23.87 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148788905 | CMS |
| Tarsus Pharmaceuticals, Inc. | $19.96 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139106077 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.